Ezetimibe and Atorvastatin Therapy on TCFA

Clinical trial NCT02588235 · UNKNOWN

Trial details

NCT number: NCT02588235
Sponsor: Xijing Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2015-10-01
Primary completion: 2017-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.